Estrogen and progesterone receptors status in Thai female breast cancer patients : An analysis of 399 cases at King Chulalongkorn Memorial Hospital

Journal of the Medical Association of Thailand

Volumn 85, Issue SUPPL. 1, 2002, Pages

  Lertsanguansinchai, Prasert ^a   Chatamra, Kris ^a   Wannakrairot, Pongsak ^a   Shotelersuk, Kanjana ^a   Boonjunwetwat, Darunee ^a   Chottetanaprasith, Taywin ^a   Sampatanukul, Pichet ^a   Rojpornpradit, Prayuth ^a   Lertbutsayanukul, Chawalit ^a   Vajragupta, Laddawan ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Breast Cancer; Estrogen Receptor; Progesterone Receptor

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TUMOR MARKER;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BREAST TUMOR; CANCER STAGING; CLIMACTERIUM; COMPARATIVE STUDY; FEMALE; HUMAN; METABOLISM; MIDDLE AGED; NEEDLE BIOPSY; PAGET NIPPLE DISEASE; PATHOLOGY; POSTMENOPAUSE; PROGNOSIS; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CLIMACTERIC; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; POSTMENOPAUSE; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0036596594     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Greenlee RT, Murray T, Bolden S, et al. Cancer statistics. CA Cancer J Clin 2000; 50:7.
2. Derarasamee S, Martin N, Sontipong S, et al. Cancer in Thailand. Vol. II. Bangkok: National Cancer Institute, 1999: 56-9.
3. Tumor registry statistical report 1999. King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand.
4. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: An overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 1998; 351: 1451-67.
5. Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the breast. Philadelphia: Lippincott Williams & Wilkins, 2000: 471-88.
6. Elledge RM, Fuqua SAW. Estrogen and progesterone receptors. In: Harris JR, Lippman ME, Morrow M, Osborne CK, editors. Disease of the breast. Philadelphia: Lippincott Williams & Wilkins, 2000: 471-88.
7. Collett K, Hartveit F. Prognostic role of estrogen and progesterone receptors in patients with breast cancer: Relation to age and lymph node status. J Clin Pathol 1996; 49: 920-5.
8. Hawkins RA. Receptors in the management of breast cancer. Br J Hosp Med 1985; 34: 160-4.
9. Brooks SC, Saunders DE, Singhakowinta A, Vaitkevicius VK. Relation of tumor content of estrogen and progesterone receptors with response of patient to endocrine therapy. Cancer 1980; 46: 2775-8.
10. Elledge RM, Clark GM, Chamness GC, Osborne CK. Tumor biologic factors and breast cancer prognosis among white, Hispanic and black women in the United States. J Natl Cancer Inst 1994; 86: 705-12.
11. Eley JW, Hill HA, Chen VW, et al. Racial differences in survival from breast cancer: Results of the National Cancer Institute black/white cancer survival study. JAMA 1994; 272; 947-54.
12. Gordon NH, Crowe JR, Brumberg DJ, Berger NA. Socioeconomic factors and race in breast cancer recurrence and survival. Am J Epidemiol 1992; 135: 609-18.
13. Hawkins RA, White G, Bundred NJ, et al. Prognostic significance of estrogen and progesterone receptor activities in breast cancer. Br J Surg 1987; 74: 1009-13.
14. Sampatanukul P, Wannakrairot P, Ruangwejworachai P, Tangwongsiri M, Viratchai C. Immunohistochemical detection of hormonal receptors and proliferative index in breast carcinoma. Chula Med J 1995; 39: 329-35.
15. Cote RJ, Taylor CR. Immunohistochemlcal detection of steroid hormonal receptors. In : Taylor CR, Cote RJ (eds) Immunomicroscopy : A Diagnostic Tool for Surgical Pathologist. Philadelphia: Saunders, 1994: 277-91.
16. th ed. Philadelphia: Lippincott -Raven, 1997: 171-80.
17. nd ed, Geneva: World Health Organization, 1981: 19.
18. Chu KC, Anderson WF, Fritz A, Ries LAG, Brawley OW. Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status of eight racial/ ethnic groups. Cancer 2001; 92: 37-45.
19. Tepmongkol P, Suphaphongs N, Chantarakul N, Thansakul A. Tamoxifen in the treatment of advanced breast cancer clinical experience at Siriraj Hospital. J Med Assoc Thai 1986; 69: 68-102.
20. Tepmongkol P, Suphaphongs N, Chantarakul N, Thansakul A. Tamoxifen in the treatment of stage II breast cancer clinical experience at Siriraj Hospital. J Med Assoc Thai 1984; 67: 670-6.
21. Rayter Z. Steroid receptors in breast cancer. Br J Surg 1991; 78: 528-35.
22. Liggman LE, Allegra JC. Estrogen receptor and endocrine therapy of breast cancer. N Eng J Med 1978; 299: 930-3.
23. Mc Guire WL, Horwitz KB, Zava DT, et al. Hormones in breast cancer, update 1978. Metabolism 1978; 27:487-501.
24. Mc Guire WL. Hormone receptors : Their role in predicting prognosis and response to endocrine therapy. Semin Oncol 1978; 5: 428-32.
25. Thorpe SM. Estrogen and progesterone receptor determinations in breast cancer: Technology, histology and clinical significance. Acta Oncol 1988; 27: 1-19.
26. Mc Guire WL. Prognostic factors in primary breast cancer. Cancer Surg 1986; 5: 527-36.
27. Lesser MI, Rosen PP, Senie RT, Duthie K, Menendez-Botet C, Schwartz MK. Estrogen and progesterone receptors in breast carcinoma : Correlations with epidemiology and pathology. Cancer 1981; 48: 299-309.
28. Fisher ER, Redmond CK, Lin H, Rockette H, Fischer B and collaborating NSABP investigators. Correlations of estrogen receptor and pathologic characteristic of invasive breast cancer. Cancer 1980; 45: 349-53.
29. Wils JM, Bliss MR, Marty M, et al. Epirubicin plus tamoxifen versus tamoxifen alone in nodepositive post-menopausal patients with breast cancer: A randomized trial of the International Collaborative Cancer Group. J Clin Onco 1999; 17: 1988-98.
30. Susan M, Joser D, Peter G, Susan C, David PW. Hormonal receptor status of breast tumor in black, hispanic and non-hispanic white women, an analysis of 13,239 cases. Cancer 1996; 77:1465-71.